FRED X – Will surface treatment be a game changer in flow diversion?

From LINNC Paris 2022, Professors Laurent Pierot and Markus A. Möhlenbruch take a deeper look at the innovative FRED X technology and discuss how surface treatment could positively impact on neurovascular strategies in the future.

Outlining preliminary data from the FRED X multicentric series, Prof. Möhlenbruch discusses the FRED X technology, a proprietary nanoscale surface treatment developed by Terumo and designed to reduce material thrombogenicity while maintaining natural healing response.